We are live on ! Find out more
MIRA icon

MIRA Pharmaceuticals
MIRA

25 hedge funds and large institutions have $3.35M invested in MIRA Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

77% more capital invested

Capital invested by funds: $1.89M → $3.35M (+$1.45M)

2.02% less ownership

Funds ownership: 7.32% → 5.29% (-2%)

14% less funds holding

Funds holding: 29 → 25 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$671K
2
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings
Hong Kong
+$460K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$200K
4
Northern Trust
Northern Trust
Illinois
+$35.2K
5
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
+$29.4K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$63.5K
2
JWCA
J.W. Cole Advisors
Florida
-$61.9K
3
Two Sigma Investments
Two Sigma Investments
New York
-$27.4K
4
XT
XTX Topco
Cayman Islands
-$22.1K
5
VF
Virtu Financial
New York
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$997K +$671K +456,854 +224%
CSI
2
Cross Staff Investments
New York
$543K – – –
Mirae Asset Global ETFs Holdings
3
Mirae Asset Global ETFs Holdings
Hong Kong
$472K +$460K +312,777 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$412K +$200K +136,438 +100%
BlackRock
5
BlackRock
New York
$166K – – –
SEM
6
Suncoast Equity Management
Florida
$156K – – –
Northern Trust
7
Northern Trust
Illinois
$102K +$35.2K +23,966 +55%
FAB
8
First American Bank
Illinois
$90.6K +$14.7K +10,000 +20%
State Street
9
State Street
Massachusetts
$74.1K – – –
IAIM
10
International Assets Investment Management
Florida
$52.9K – – –
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$45.6K – – –
Two Sigma Investments
12
Two Sigma Investments
New York
$40.8K -$27.4K -18,659 -41%
Creative Planning
13
Creative Planning
Kansas
$34.1K – – –
AQR Capital Management
14
AQR Capital Management
Connecticut
$33.2K – – –
XT
15
XTX Topco
Cayman Islands
$31.6K -$22.1K -15,019 -42%
Fifth Third Bancorp
16
Fifth Third Bancorp
Ohio
$30.2K +$29.4K +20,000 New
Mariner
17
Mariner
Kansas
$24.9K – – –
CSP
18
Cary Street Partners
Virginia
$15.1K – – –
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
$12.1K +$1.47K +1,000 +14%
UBS Group
20
UBS Group
Switzerland
$4.08K +$3.65K +2,484 +1,150%
Osaic Holdings
21
Osaic Holdings
Arizona
$3.02K – – –
SPIA
22
Steward Partners Investment Advisory
New York
$3.02K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$2.76K +$48 +33 +2%
Bank of America
24
Bank of America
North Carolina
$395 +$178 +121 +86%
Wells Fargo
25
Wells Fargo
California
$35 – – –
1
2

MIRA Hedge Fund Activity: Q4 2025 in Review

25 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q4 2025, worth a combined $3.35M — up 77% from $1.89M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MIRA and 2 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 8 added.

The largest buyer was Vanguard Group, adding an estimated $671K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $63.5K sold.

  • 25 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q4 2025, down from 29 in Q3 2025.
  • Funds reported $3.35M of MIRA Pharmaceuticals stock for Q4 2025, up 77% quarter-over-quarter.
  • 2 funds opened new MIRA Pharmaceuticals positions in Q4 2025 and 6 closed out, a net change of -4 holders.
  • The largest MIRA Pharmaceuticals buyer in Q4 2025 was Vanguard Group, an estimated $671K added.
  • The largest MIRA Pharmaceuticals seller in Q4 2025 was Renaissance Technologies, an estimated $63.5K sold.

Based on aggregated 13F filings for Q4 2025.